Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers

Gür M., Yıldız A., Demirbağ R., Yilmaz R., Aslan M., Ozdogru I., ...More

CORONARY ARTERY DISEASE, vol.18, no.2, pp.89-95, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 2
  • Publication Date: 2007
  • Doi Number: 10.1097/mca.0b013e32801104e8
  • Journal Name: CORONARY ARTERY DISEASE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.89-95
  • Keywords: antioxidant, arylesterase, cardiac syndrome X, high-density lipoprotein, lipid hydroperoxide, paraoxonase, CORONARY-ARTERY-DISEASE, HUMAN-SERUM PARAOXONASE, LOW-DENSITY-LIPOPROTEIN, LIPID HYDROPEROXIDES, AUTOMATED-METHOD, ANGINA-PECTORIS, HEART-DISEASE, ATHEROSCLEROSIS, PROTEIN, DAMAGE
  • Akdeniz University Affiliated: No

Abstract

Objectives Paraoxonase-1 is a high-density lipoprotein-associated enzyme with three activities, which are paraoxonase, arylesterase and dyazoxonase. Paraoxonase-1 was shown to decrease in patients with cardiovascular diseases. We aimed to examine serum paraoxonase and arylesterase activities, and their relation with oxidative stress markers such as lipid hydroperoxide and total antioxidant status in patients with cardiac syndrome X.